Skip to main content

Advertisement

Table 2 Infection burdens of groups receiving different treatments post-infection

From: Enhanced antifungal activity of bovine lactoferrin-producing probiotic Lactobacillus casei in the murine model of vulvovaginal candidiasis

Treatment Infection burden of VVC (log10 CFU)
Before treatment After treatment
PBS 4.76 ± 0.341 3.738 ± 0.231
Clotrimazole 4.766 ± 0.284 0.492 ± 0.170a*
L.casei/pPG612.1-BLF 4.76 ± 0.310 1.710 ± 0.390b*
L.casei/pPG612.1 4.782 ± 0.279 3.170 ± 0.252c
L.casei 4.746 ± 0.333 2.936 ± 0.259
  1. a*P < 0.01 in comparison with L.casei/pPG612.1-BLF
  2. b*P < 0.01 in comparison with L.casei/pPG612.1, L.casei and PBS
  3. cp > 0.05 in comparison with L.casei